Printer Friendly

Hypocalcemia in jaundiced neonates receiving phototherapy.

Byline: Mashal Khan, Kanwal Altaf Malik and Rekha Bai

ABSTRACT

Objective: To determine the frequency of hypocalcemia in term neonates with jaundice receiving phototherapy.

Methods: This was a cross sectional study conducted at Neonatal intensive care unit, National Institute of Child Health, Karachi from 1st January 2014 to 30th December 2014. A total of 123 term neonates with jaundice of either gender managed by phototherapy were enrolled in the study. Gestational age was assessed through modified Ballard scoring. Duration of phototherapy was recorded. A sample of 3 ml of blood was sent to the laboratory for serum calcium level before initiating phototherapy and after 24 hours of continued phototherapy. All the data were recorded in the preformed proforma. Data was analyzed using SPSS version 19. P value <0.05 was taken as significant.

Results: The mean age of the neonates was 8.35+-6.74 days.Mean gestational age at the time of birth was 39.08+-1.37 weeks. Mean duration of jaundice was 2.4+-1.20 days. Mean duration of phototherapy was 1.74+-0.98 days. Serum calcium level before and after 24 hours of initiating phototherapy was 8.73+-0.68 mg/dl and 7.47+-0.82mg/dl respectively Frequency of hypocalcemia in term jaundiced neonates receiving phototherapy were observed in 22.76% (28/123).

Conclusions: The frequency of hypocalcemia is significant in the jaundiced neonates treated with phototherapy. One needs to be vigilant in dealing neonates in this context while serial monitoring for hypocalcemia and its complications should be considered in institutional policy and research priority.

KEY WORDS: Hypocalcemia, Term neonates, Jaundice, Phototherapy.

INTRODUCTION

Jaundice is a common cause of morbidity encountered in the first week of life. It is an utmost concern for the physician and a source of anxiety for the parents.1 High bilirubin level may be toxic to the developing central nervous system and may elicit neurological impairment in newborns.2 About 60% of term newborns become visibly jaundiced in the first week of life. In most of the cases, it is benign and no intervention is required. Approximately 5-10% of them have clinically significant jaundice that signifies the use of phototherapy.4

Jaundice is attributable to physiological immaturity of neonates to manage increased bilirubin production. Visible jaundice usually appears between 24-72 hours of age. Basic pathophysiology of jaundice is same in term and preterm neonates, but premature babies are at a higher risk of developing jaundice.5 Phototherapy is the most commonly used intervention to treat and prevent severe jaundice. It reduces the risk of exchange transfusion.6 It blunts the rise of bilirubin level regardless of the etiology of jaundice.7 Though it is considered safe, a few side effects encountered in phototherapy are loose stools, hyperthermia, dehydration due to fluid loss, skin burn, photo retinitis, low platelet count, increased red cell osmotic fragility, bronze baby syndrome, riboflavin deficiency and DNA damage. A lesser known side effect, but a potential complication of phototherapy is hypocalcemia.8

The overall prevalence of hypocalcemia in neonates receiving phototherapy was suggested to be 8.7% in full-term newborn.9 Another study reflects a little difference between pre and post phototherapy plasma calcium levels (p<0.05).10

The relation of hypocalcemia with phototherapy is an important aspect to be considered due to the potential complications of hypocalcemia. This study aimed to cater the burden of hypocalcemia in term neonates treated with phototherapy so as to highlight this aspect, that can further emphasize in modifying local strategies and research priorities.

METHODS

This cross sectional study was conducted at Neonatal intensive care unit of National Institute of Child Health, Karachi with effect from 1st January 2014 to 30th December 2014. A total of 123 neonates were included in the study. They were term neonates with jaundice requiring phototherapy for at least one day and had a normal calcium level before initiating phototherapy. Informed consent was taken from their parents/guardians. Neonates with jaundice requiring exchange transfusion, birth asphyxia, sepsis, respiratory distress and infants of diabetic mother were excluded from the study. Clearance from institutional ethical review committee was also taken.

Sample size was calculated using software package of WHO. The frequency of hypocalcemia in neonates with jaundice was calculated on the basis of a previous study.9 A total of 123 newborn patients were required to achieve 5% level of significance and 5% born on error of estimation. Sampling technique was non probability consecutive sampling. History and examination was performed on every patient. Gestational age was assessed through modified Ballard scoring. Weight and duration of phototherapy was recorded. Hypocalcemia was defined as a total serum calcium level of <8 mg/dL in a term neonate.11 A sample of 3ml venous blood was sent to the laboratory for serum calcium level before starting conventional phototherapy and after 24 hours of continuous phototherapy. The data was recorded in a predesigned proforma. Data entry and analysis was done using SPSS version 19. Frequency and percentage was computed for categorical variable like sex and hypocalcemic status.

Mean and standard deviations was computed for continuous variables like age, gestational age, duration of phototherapy and duration of jaundice. Effect modifiers like age, sex, gestational age, duration of jaundice and duration of phototherapy was controlled through stratification by applying chi squared test and p-value <0.05 was considered significant.

Table-I: Descriptive statistics of the age, gestational age and duration of jaundice.

###Descriptive statistics###Age (Days)###Gestational Age (Weeks)###Duration of Jaundice (Days)

###Mean###8.35###39.08###2.41

###Std. Deviation###6.74###1.37###1.20

###95% Confidence Interval of Mean Lower Bound###7.15s###38.84###2.18

###Upper Bound###9.55###39.33###2.61

###Median###6###29###2

###Interquartile Range###9###2###2

RESULTS

A total of 123 term neonates included 77 (62.6%) male and 46(37.4%) female. Most of the neonates were 20 days###1(12.5%)###7(87.5%)###8

Gender

Male###14(18.2%)###63(81.8%)###77

Female###14(30.4%)###32(69.6%)###46

Gestational Age (Weeks)

37+1 to 40###24 (23.5%) 78(76.5%)###102

> 40###4(19%)###17(81%)###21

Duration of Phototherapy

1 day###21(21.6%)###76(78.4%)###97

2 to 5 days###7(26.9%)###19(73.1%)###26

Duration of Jaundice

1 to 3 days###22(22.2%)###77(77.8%)###99

> 3 days###6(25%)###18(75%)###24

In our study the mean age of the neonates and gestational age at the time of birth was 8.35+-6.74 days and 39.08+-1.37 weeks. There were 77 (62.6%) male and 46 (37.4%) female. This matches the study by Kramifer H et al. that included the mean age of 5.69+-2.6 days.18

Our study shows 22.76% (28/123) of term neonates exhibited phototherapy induced hypocalcemia. In Iran, a study reflects 7% of term neonates with phototherapy induced hypocalcemia.19 Ehsanipoor et al. and Karamifar et al. reported the incidence of hypocalcemia to be 15% and 8.7% respectively.20,21 Jain BK et al. after 48 hours of continuous phototherapy observed hypocalcemia in 30% of term neonates.22 In contrast much higher frequency was observed by Yadavs, about 66.6% of neonates developed hypocalcemia after phototherapy.9 Also Medhat found hypocalcemia in 75% of term neonates after phototherapy.23 A Latest study by Bahbah et al. done in 2014 at Egypt studied only 50 term neonates who received phototherapy for jaundice and 25 neonates were taken as controls with physiological jaundice needing no phototherapy. After 48 hours of phototherapy hypocalcemia was found in 26%.24

The effectiveness of phototherapy in the management of neonatal jaundice is well known. The efforts made round the globe recognize it as a potential complication with variable results some reflecting more severe hypocalcemia than others, considering the duration of phototherapy exposure, the severity of hyperbilirubinemia when phototherapy was initiated and also the term neonate versus preterm neonates. All these factors add to the severity of hypocalcemia induced by phototherapy. Our study explains a significant effect of phototherapy on the calcium balance in a term neonate with jaundice, receiving phototherapy. Further studies are needed to elaborate this aspect further, to suggest if calcium supplementation were to given in neonates who receive phototherapy for neonatal jaundice.

CONCLUSIONS

Our study concludes that a significant number of neonates i.e. 22.6% developed hypocalcemia after phototherapy. The range of hypocalcemia varied from very low levels to just borderline decrease in total calcium. This in turn can have clinical impact and adds to the morbidity. Hence this study is helping us many folds, to raise our concern towards another impact of phototherapy while alleviating jaundice on other hand. This adds to our institutional policies and research priorities.

Grant support and final disclosure: None.

Disclosure: None.

REFERENCES

1. De Luca D. NICE guidelines on neonatal jaundice: at risk of being too nice. Lancet. 2010;376(9743):771. doi: 10.1016/ S0140-6736(10)61376-1.

2. Kaplan M, Bromiker R, Hammerman C. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology. 2011;100(4):354-362. doi:10.1159/000330055.

3. Dijk P, de Vries T, de Beer J. Guideline' Prevention, diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age of 35 or more weeks'. Nederlands Tijdschrift Voor Geneeskunde. 2009;153:93.

4. Hansen TWR. Twists and turns in phototherapy for neonatal jaundice. Acta Paediatrica. 2010;99(8):1117-1118. doi: 10.1111/j.1651-2227.2010.01898.

5. Walsh S, Murphy J. Neonatal jaundice--are we overtreating? Iran Med J. 2010;103(1):28-29.

6. Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114(1):130-153.

7. Maisels MJ, Kring E. Rebound in serum bilirubin level following intensive phototherapy. Arch Pediatr Adolescent Med. 2002;156(7):669-672. doi:10.1001/archpedi.156.7.669.

8. Cloherty JP, Eichenwald EC, Stark AR. Manual of neonatal care: Lippincott Williams and Wilkins; 2008.

9. Yadav RK, Sethi R, Sethi AS, Kumar L, Chaurasia OS. The evaluation of the effect of phototherapy on serum calcium level. People's J Sci Res. 2012;5(2):1-4.

10. Eghbalian F, Monsef A. Phototherapy-induced hypocalcemia in icteric newborns. Iran J Med Sci. 2002;27(4):169-171.

11. Jain A, Agarwal R, Sankar MJ, Deorari A, Paul VK. Hypocalcemia in the newborn. Indian J Pediatr. 2010;77(10):1123-1128. doi: 10.1007/s12098-010-0176-0.

12. Burke BL, Robbins JM, Mac Bird T, Hobbs CA, Nesmith C, Tilford JM. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics. 2009;123(2):524-532. doi:10.1542/peds.2007-2915.

13. Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(1):86-100. doi:10.1038/pr.2013.208.

14. Romagnodi C, Polidori G, Cataldi L, Tortorolo G, Segni G. Phototherapy-induced hypocalcemia. J Pediatr. 1979;94(5):815-816.

15. Altirkawi K, Rozycki HJ. Hypocalcemia is common in the first 48 h of life in ELBW infants. J Perinatal Med. 2008;36(4):348-353. doi: 10.1515/JPM.2008.051.

16. Hakanson D, Penny R, Bergstrom W. Calcemic responses to photic and pharmacologic manipulation of serum melatonin. Pediatr Res. 1984;18:168A-A. doi:10.1203/00006450-198404001-00452.

17. Hunter K. Hypocalcemia. Manual of Neonatal Care 5th ed Philadelphia: Lippincott Williams and Wilkins. 2004:579-88.

18. Karamifar H, Pishva N, Amirhakimi G. Prevalence of phototherapy-induced hypocalcemia. Iranian J Med Sci. 2015;27(4):166-168.

19. Alizadeh-Taheri P, Sajjadian N, Eivazzadeh B. Prevalence of phototherapy induced hypocalcemia in term neonate. Iran J Pediatr. 2013;23(6):710-711.

20. Ehsanipour F, Khosravi N, Jalali S. The Effect of Hat on Phototherapy-Induced Hypocalcemia in Icteric Newborns. Razi J Med Sci. 2008;15(58):25-29.

21. Karamifar H, Amir HG, Pishva N. Prevalence of phototherapy-induced hypocalcemia. Iran J Med Sci. 2002;27(4):166-168.

22. Jain B, Singh H, Singh D, Toor N. Phototherapy induced hypocalcemia. Indian Pediatr. 1998;35(6):566-567.

23. Medhat F. Assessment of phototherapy induced hypocalcaemia: Thesis submitted for M. Sc. Pediatrics in Cairo University. Classification; 2006.

24. Bahbah MH, ElNemr FM, ElZayat RS, Aziz EAK. Effect of phototherapy on serum calcium level in neonatal jaundice. Menoufia Med J. 2015;28(2):426-430. doi: 10.4103/1110-2098.163896.
COPYRIGHT 2016 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Pakistan Journal of Medical Sciences
Geographic Code:7IRAN
Date:Dec 31, 2016
Words:2258
Previous Article:Depression, anxiety and stress among female patients of infertility; A case control study.
Next Article:Detection of AmpC b-lactamase producing bacteria isolated in neonatal sepsis.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters